Skip to main content
. 2010 Aug 3;59(10):2682–2689. doi: 10.2337/db10-0177

TABLE 2.

Association between maternal GCK rs1799884 genotype and maternal glucose levels in pregnancy

Total N Mean ± SE plasma glucose level by GCK rs1799884 genotype
Effect size ± SE per T-allele (mmol/l)* P
CC CT TT
FPG (mmol/l)
    European 3,811 4.55 ± 0.01 4.59 ± 0.01 4.63 ± 0.03 0.03 ± 0.01 0.001
    Thai 1,706 4.42 ± 0.01 4.51 ± 0.02 4.52 ± 0.08 0.08 ± 0.02 <0.0001
1-h plasma glucose (mmol/l)
    European 3,811 7.39 ± 0.03 7.54 ± 0.05 7.69 ± 0.15 0.15 ± 0.05 0.001
    Thai 1,706 8.25 ± 0.05 8.35 ± 0.09 8.54 ± 0.37 0.11 ± 0.09 0.24
2-h plasma glucose (mmol/l)
    European 3,811 6.11 ± 0.02 6.12 ± 0.04 6.18 ± 0.11 0.02 ± 0.04 0.56
    Thai 1,706 6.61 ± 0.04 6.85 ± 0.08 6.81 ± 0.30 0.21 ± 0.07 0.005

The European plasma glucose levels by genotype are the mean values across all four field centers. These are presented separately in supplementary Table 1.

*The T-allele of GCK rs1799884 is associated with raised fasting glucose in nondiabetic, nonpregnant populations. The T-allele frequency ranged from 17.1 to 18.7% in the European ancestry samples and was 10.3% in the Thai samples.

†The effect sizes and P values are from linear regression of maternal glucose level against genotype (coded 0, 1, or 2 T-alleles), with field center (European ancestry only), age, BMI, and mean arterial pressure as covariates. Age, BMI, and mean arterial pressure were measured at a median of 28–29 weeks' gestation, depending on the field center. Mean ± SE values are adjusted for these three covariates. FPG, fasting plasma glucose.